Stomach balloon study aims to help people with obesity shed pounds safely
NCT ID NCT07062094
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks 200 adults with obesity in the EU who choose to get the Orbera365 intragastric balloon. The balloon is placed in the stomach and filled with saline to help people feel full and eat less. Researchers will monitor serious side effects and how much weight participants lose over up to 12 months with the balloon in place.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
intragastric balloon (Orbera365)
What this could lead to
If successful, this could confirm that the Orbera365 balloon is a safe and effective tool for significant weight loss in people with obesity.
What could go wrong
This is an observational registry, not a controlled trial, so results may be less definitive. Risks include serious complications like blockage or balloon deflation requiring hospital care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dorsia Clinic, Madrid Spain
NOT_YET_RECRUITINGMadrid, Spain
Contact
Contact
-
EndoBes - Centre Medico Teknon
RECRUITINGBarcelona, Spain
Contact
Contact
-
Hôpital Avicenne
NOT_YET_RECRUITINGBobigny, France
Contact
Contact
-
OB Klinika
RECRUITINGPrague, Czechia
Contact
Contact
-
UHCW NHS Trust
NOT_YET_RECRUITINGCoventry, West Midlands, CV2 2DX, United Kingdom
Contact
Contact